Literature DB >> 9814686

Significance of IgA antiphospholipid antibodies.

W A Wilson1, Z Faghiri, F Taheri, A E Gharavi.   

Abstract

IgA anticardiolipin (IgA aCL) and IgA anti beta2-glycoprotein-I (IgA anti beta2GP1) antibodies are common in SLE and have been associated in some studies with thromboses and thrombocytopenia. Experimental work suggests that IgA aCL are as prothrombotic as the IgG-IgM isotypes. However, in SLE there appears to be less concordance between IgA aCL and IgA anti beta2GP1 as compared with the concordance between IgG and IgM isotypes, suggesting significant differences in their origins and specificities. For example, there may be a greater mucosal contribution to production of IgA antibeta2GP1 than IgA aCL. Infections may have a greater role in the presence of IgA aCL than IgA antibeta2GP1 antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814686     DOI: 10.1177/096120339800700225

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura.

Authors:  Y H Yang; M T Huang; S C Lin; Y T Lin; M J Tsai; B L Chiang
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 2.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

Review 3.  Recent advances in the diagnosis of antiphospholipid syndrome.

Authors:  Hyun-Sook Chi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome.

Authors:  Vijaya Shaharao; Sandip Bartakke; Mamta N Muranjan; Manisha S Bavdekar; Sandeep B Bavdekar; Vrajesh P Udani
Journal:  Indian J Pediatr       Date:  2004-06       Impact factor: 1.967

5.  Guillain-Barré syndrome as first presentation of systemic lupus erythematosus: a rare manifestation complicated by IVIg-induced splenic infarct.

Authors:  Richard M Fazio; Ioana Chen; Navjot Somal
Journal:  BMJ Case Rep       Date:  2015-11-25

6.  Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.

Authors:  Hyemee Joo; Christine Coquery; Yaming Xue; Ingrid Gayet; Stacey R Dillon; Marilynn Punaro; Gerard Zurawski; Jacques Banchereau; Virginia Pascual; Sangkon Oh
Journal:  J Exp Med       Date:  2012-06-11       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.